Assignee
LYVGEN BIOPHARMA CO LTD
CN·1 granted patent·1 pending application·2 citations·filing 2021–2021
Top patents by PatentIndex Score
2 records- 0186US11186648B2Anti-CD40 antibody having engineered Fc domains and therapeutic uses thereofLYVGEN BIOPHARMA CO LTD·Filed 2021·Granted Nov 30, 2021·2 cites·11 claims
- 0259US2022081487A1Anti-cd40 binding molecules having engineered fc domains and therapeutic uses thereofLYVGEN BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LYVGEN BIOPHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →